NEUROLOGIX, INC. Inactive Instrument
Neurologix, Inc. Stock OTC Bulletin Board
Equities
US64125U4067
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Neurologix, Inc. engages in the research and development of gene transfer therapies for the treatment for brain disorders and central nervous system diseases. The company programs address conditions such as Parkinson's disease, epilepsy, depression and Huntington's disease.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.67% | 47.9B | |
| +46.56% | 41.42B | |
| -2.39% | 40.7B | |
| -6.20% | 28.92B | |
| +10.67% | 25.55B | |
| -21.57% | 19.27B | |
| -2.42% | 12.15B | |
| +31.15% | 12.14B | |
| -0.85% | 11.99B |
